Zolium 0.25 mg is a prescription medication belonging to the benzodiazepine sedatives class. It is primarily indicated for the management of anxiety disorders, short-term relief of anxiety, anxiety associated with depression, and panic disorder, with or without agoraphobia. Zolium 0.25 mg works by enhancing the activity of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the central nervous system, which produces a calming effect and reduces excessive neuronal activity.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class
Benzodiazepine sedatives

Pharmacology
Zolium 0.25 mg binds with high affinity to the GABA-benzodiazepine receptor complex, including BNZ1 and BNZ2 receptors. This interaction increases the effects of GABA, opening chloride channels in neurons, hyperpolarizing cell membranes, and reducing excitability. The result is anxiolytic, hypnotic, anticonvulsant, and muscle-relaxant effects, depending on the dose and patient response.

Indications

• Anxiety disorder

• Short-term relief of anxiety

• Anxiety associated with depression

• Panic disorder, with or without agoraphobia

Dosage & Administration

• Adults: Start with 0.25 mg two or three times daily. Dose may be increased in 0.25 mg increments depending on symptom severity and patient response. Evening doses may be increased before daytime doses. Maximum usual daily dose: 3 mg, though some patients with severe panic disorder may require up to 10 mg daily under careful supervision.

• Elderly/Debilitated Patients: Start with 0.125 mg two or three times daily. Gradual dose increase may be considered based on tolerance and clinical response.

• Special Considerations: Therapy should be individualized, aiming for the lowest effective dose. Discontinuation should be gradual, reducing by no more than 0.5 mg every three days. Tablets must be taken whole and not crushed or chewed.

Contraindications

• Hypersensitivity to Zolium 0.25 mg or other benzodiazepines

• Myasthenia gravis

• Acute narrow-angle glaucoma

• Pregnancy and breastfeeding

• Infants

Precautions & Warnings

• Risk of psychological and physical dependence

• Use with caution in patients with hepatic or renal impairment, chronic pulmonary disease, or sleep apnea

• Avoid abrupt discontinuation without medical supervision

Side Effects
Common side effects may include drowsiness and light-headedness. Other possible effects: depression, headache, confusion, dry mouth, constipation. Most side effects are mild and often resolve with continued therapy.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Drug Interactions
The CNS depressant effect of Zolium 0.25 mg may be potentiated by alcohol, other psychotropic drugs, anticonvulsants, antihistamines, and oral contraceptives.

Overdose
Symptoms of overdose include somnolence, confusion, impaired coordination, diminished reflexes, and coma. Immediate medical attention and supportive care, including gastric lavage, are recommended.

Pregnancy & Lactation
Zolium 0.25 mg is categorized as pregnancy category D and is not recommended during pregnancy. The drug and its metabolites are excreted in breast milk; breastfeeding should be avoided during treatment.

Storage
Store below 30°C, away from light and moisture. Keep out of reach of children.

Use in Special Populations

• Children (<18 years): Safety and efficacy not established

• Elderly: Lower initial dose recommended

Mode of Action
Zolium 0.25 mg is a triazole analog of 1,4-benzodiazepines. Its anxiolytic, hypnotic, and anticonvulsant effects are mediated through potentiation of GABA at the GABA-benzodiazepine receptor complex, producing CNS depressant activity in a dose-dependent manner.